Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation

[1]  J. D. White,et al.  Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Tomonaga,et al.  Adult T‐cell leukemia cells over‐express the multidrug‐resistance‐protein (MRP) and lung‐resistance‐protein (LRP) genes , 1999, International journal of cancer.

[3]  M. Tomonaga,et al.  Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature , 1999, Bone Marrow Transplantation.

[4]  T. Okamura,et al.  Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation , 1998, The Lancet.

[5]  C. Wittwer,et al.  Continuous fluorescence monitoring of rapid cycle DNA amplification. , 1997, BioTechniques.

[6]  Shinsuke Suzuki,et al.  Treatment for adult T-cell leukemia , 1997, Cancer Chemotherapy and Pharmacology.

[7]  J. Tosswill,et al.  Successful treatment of HTLV‐1‐associated acute adult T‐cell leukaemia lymphoma by allogeneic bone marrow transplantation , 1996, British journal of haematology.

[8]  M. Tomonaga,et al.  An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[9]  M. Kaplan,et al.  Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. , 1995, The New England journal of medicine.

[10]  G. Gahrton,et al.  Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV‐I) following allogeneic bone marrow transplantation for HTLV‐I positive adult T‐cell leukaemia , 1994, British journal of haematology.

[11]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[12]  K. Uozumi,et al.  Expression of P-glycoprotein in adult T-cell leukemia cells. , 1990, Blood.

[13]  J. Nishimura,et al.  Overexpression of P-glycoprotein in adult T-cell leukaemia , 1990, The Lancet.

[14]  S. Tsugane,et al.  Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  K. Tamura.  [Treatment of adult T-cell leukemia]. , 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[16]  J. Bender,et al.  Phase I Trial , 1983 .

[17]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[18]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[19]  J. Yodoi,et al.  Adult T-cell leukemia: clinical and hematologic features of 16 cases. , 1977, Blood.

[20]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[21]  H. Towler,et al.  Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .